OPAL

On the surface OPAL screens cheap — 0.2x sales, 14x earnings, revenue up 12.3% to $327M and net income up 154% to $36.4M. But the earnings quality is poor: operating income fell 65% to just $7.41M (a 2.3% operating margin), so the entire reported profit — and then some — comes from below-the-line items, not the core business. Net income five times operating income is a warning, not a virtue, and the FY history (net income swinging $40.8M→$32.6M→$127M→$14.3M→$36.4M on far steadier revenue) confirms the bottom line is driven by volatile Environmental Attribute pricing (RINs, LCFS credits) rather than durable operations. The MD&A itself flags that demand hinges on EPA renewable-volume mandates and that a reduction in RIN/LCFS prices 'could have a material adverse effect' — an exogenous, regulator-set input the company cannot control.

The balance sheet is the real problem. Stockholders' equity is negative (-$12.9M) against $361M of long-term debt (+17.5%) and only $24.4M of cash. The business is not self-funding: FY2025 capex of $70.7M nearly doubled operating cash flow of $36.5M, so OPAL burned roughly $34M of free cash and is plugging the gap with leverage and expensive equity. The March 2026 financing makes this concrete — OPAL took $120M of Series A preferred paying 12% per annum compounding, senior to the common, and drew $128.4M more on its term loan, largely to redeem NextEra's $100M preferred. Trading one expensive senior claim for another 12% claim ahead of common holders is dilutive to equity value even as the P/E looks benign.